Role of 2-Deoxy-D-Glucose (2-DG) in COVID-19 disease: A potential game-changer

KK Sahu, R Kumar - Journal of Family Medicine and Primary Care, 2021 - journals.lww.com
Virus infections can cause tissue damage in many ways. Severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2), a cause of the current COVID-19 pandemic, has been …

Machine learning and comorbidity network analysis for hospitalized patients with COVID-19 in a city in Southern Brazil

H Passarelli-Araujo, H Passarelli-Araujo, MR Urbano… - Smart Health, 2022 - Elsevier
The large amount of data generated during the COVID-19 pandemic requires advanced
tools for the long-term prediction of risk factors associated with COVID-19 mortality with …

Pre-existing interstitial lung disease in patients with coronavirus disease 2019: A meta-analysis

L Ouyang, J Gong, M Yu - International immunopharmacology, 2021 - Elsevier
Background The impact of pre-existing interstitial lung disease (ILD) on the severity and
mortality of COVID-19 remains largely unknown. The purpose of this meta-analysis was to …

Homeopathy as an adjuvant to standard care in moderate and severe cases of COVID-19: a single-blind, randomized, placebo-controlled study

H Kaur, S Kaushik, G Singh, A Kumar, S Singh… - …, 2023 - thieme-connect.com
Objectives This study aimed to evaluate whether individualized homeopathic medicines
have a greater adjunctive effect than adjunctive placebos in the treatment of moderate and …

The Impact of Comorbidities on the Outcomes of Egyptian COVID‐19 Patients: A Follow‐Up Study

RM Albadawy, BA Jadoon… - … and Public Health, 2021 - Wiley Online Library
Objectives. This study evaluated the clinical manifestation of COVID‐19 and adverse
outcomes in patients with comorbidities (outcome: death). Methods. A comparative follow‐up …

Molecular signatures in the progression of COVID-19 severity

R De, RK Azad - Scientific Reports, 2022 - nature.com
SARS-CoV-2 is the causative agent of COVID-19 that has infected over 642 million and
killed over 6.6 million people around the globe. Underlying a wide range of clinical …

A study of hospitalized COVID-19 patients with AKI in a setting of multiracial developing country

SH Ooi, KP Ng, P Sthaneshwar, SK Lim, PY Khor… - BMC nephrology, 2024 - Springer
Background The commonest indication for hospitalization in COVID-19 patients is
hypoxemia or severe respiratory symptoms. However, COVID-19 disease may result in …

Clinical and Laboratory Features of COVID-19 in Ulin Referral Hospital of South Kalimantan: Predictors of Clinical Outcome.

M Isa, A Assagaf, I Nurrasyidah… - Journal of Tropical …, 2021 - search.ebscohost.com
Abstract Corona Virus Disease (COVID-19) is becoming a global pandemic. Indonesia,
especially South Kalimantan had recorded increasing cases with a high fatality rate of 3.7 …

An interesting finding: What is the relation between aortic enlargement and COVID-19?

M Bitargil, T Demir, HK Çetin, N Bektaş… - …, 2023 - journals.sagepub.com
Background We aim to compare the diameters of ascending aorta in COVID-19 patients and
COVID–19-free individuals referred to our pandemic hospital. Methods The medical records …

Hubungan Komorbiditas terhadap Derajat Keparahan Admisi dan Outcome Pasien Covid-19

IMAA Putra, F Fenty - Journal of Health Promotion …, 2022 - jhpsm.denpasarinstitute.com
COVID-19 is a disease cause by SARS-CoV-2. One of the concerning clinical consideration
is the presence of comorbid in patients. The purpose of this research is to identify the …